CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parentheticals) - USD ($) |
3 Months Ended | |
|---|---|---|
Jan. 31, 2019 |
Jan. 31, 2018 |
|
| Research and Development Expense [Member] | ||
| Non-cash share-based compensation expenses | $ 1,573,779 | $ 40,057 |
| Selling, General and Administrative Expenses [Member] | ||
| Non-cash share-based compensation expenses | $ 1,176,385 | $ 226,916 |
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|